A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome
Veronica Marrella(Humanitas University), Anna Villa(Institute of Genetic and Biomedical Research), Marita Bosticardo(National Institutes of Health), Luigi D. Notarangelo(National Institutes of Health), Brigitte Lemercier(Inserm), Paolo Vezzoni(Humanitas University), Maria Ravanini(Brescia University), Pietro Luigi Poliani(University of Brescia), Francesca Rucci(Institute of Biomedical Technologies), Fabio Grassi(University of Milan), Laura Frascoli(Institute of Biomedical Technologies), Fabio Facchetti(University of Brescia), Manuela Battaglia(Vita-Salute San Raffaele University), Marie Lise Gougeon(Inserm), Maria Grazia Roncarolo(IRCCS Ospedale San Raffaele), Anna Casati, Marina Cavazzana(Délégation Paris 5)
Cited by 111
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k